# EDGAR Filing Document

**Accession Number:** 0001954863
**File Stem:** 0001104659-25-075350
**Filing Date:** 2025-8
**Character Count:** 14203
**Document Hash:** 0fc9392611d3aea1f517123f337094d8
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-25-075350.hdr.sgml**: 20250807

**ACCESSION NUMBER**: 0001104659-25-075350

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13D/A

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20250807

**DATE AS OF CHANGE**: 20250807

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Bioceres Crop Solutions Corp.
- **CENTRAL INDEX KEY:** 0001769484
- **STANDARD INDUSTRIAL CLASSIFICATION:** AGRICULTURE CHEMICALS [2870]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 000000000
- **STATE OF INCORPORATION:** E9
- **FISCAL YEAR END:** 0630

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-90962
- **FILM NUMBER:** 251195893

**BUSINESS ADDRESS:**
- **STREET 1:** PO BOX 309, UGLAND HOUSE
- **CITY:** GEORGE TOWN, GRAND CAYMAN
- **STATE:** E9
- **ZIP:** KY1-1104
- **BUSINESS PHONE:** 54 341 486 1122

**MAIL ADDRESS:**
- **STREET 1:** OCAMPO 210 BIS, PREDIO CCT
- **CITY:** ROSARIO
- **STATE:** C1
- **ZIP:** 2000
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Bioceres Group PLC
- **CENTRAL INDEX KEY:** 0001954863

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** X0
- **FISCAL YEAR END:** 0630

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D/A

**BUSINESS ADDRESS:**
- **STREET 1:** HIGHDOWN HOUSE, YEOMAN WAY
- **CITY:** WORTHING, WEST SUSSEX
- **STATE:** X0
- **ZIP:** BN99 3HH
- **BUSINESS PHONE:** 5403414861100

**MAIL ADDRESS:**
- **STREET 1:** HIGHDOWN HOUSE, YEOMAN WAY
- **CITY:** WORTHING, WEST SUSSEX
- **STATE:** X0
- **ZIP:** BN99 3HH

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13D

### Under the Securities Exchange Act of 1934

**(Amendment No. 15)**

**Bioceres Crop Solutions Corp.**

*(Name of Issuer)*

**Ordinary Shares, $0.0001 par value**

*(Title of Class of Securities)*

**G1117K114**

*(CUSIP Number)*

**Gloria Montaron Estrada**<br>Bioceres Group Limited<br>Highdown House, Yeoman Way, Worthing,<br>West Sussex X0 BN99 3HH<br>54 0341 4861100

*(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)*

**08/07/2025**

*(Date of Event Which Requires Filing of this Statement)*

| **CUSIP No.** | **G1117K114** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Bioceres Group Limited** | Name of reporting person<br>**Bioceres Group Limited** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**OO** | Source of funds (See Instructions)<br>**OO** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**X0** | Citizenship or place of organization<br>**X0** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**70785.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**15426617.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**70785.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**12350538.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**15497402.00** | Aggregate amount beneficially owned by each reporting person<br>**15497402.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**24.7%** | Percent of class represented by amount in Row (11)<br>**24.7%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**HC** | Type of Reporting Person (See Instructions)<br>**HC** | |

---

**Comment for Reporting Person:** Bioceres Group Limited may be deemed to be the ultimate beneficial owner of Shares held by Bioceres LLC and THEO I SCSp as Bioceres LLC is an indirect wholly-owned subsidiary of Bioceres Group Limited, and Bioceres Group Limited owns 96.2 percent of the outstanding equity securities of THEO I SCSp.

Row 8 includes 3,076,079 shares that Bioceres LLC has shareholder rights over pursuant to the Shareholders Agreement, dated as of March 5, 2019, by and between Bioceres LLC, Pedro Enrique Mac Mullen, Maria Marta Mac Mullen and International Property Services Corp. See Exhibit 10.1.

| **CUSIP No.** | **G1117K114** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Bioceres LLC** | Name of reporting person<br>**Bioceres LLC** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**OO** | Source of funds (See Instructions)<br>**OO** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**DELAWARE** | Citizenship or place of organization<br>**DELAWARE** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**14989117.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**11913038.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**14989117.00** | Aggregate amount beneficially owned by each reporting person<br>**14989117.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**23.8%** | Percent of class represented by amount in Row (11)<br>**23.8%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**HC** | Type of Reporting Person (See Instructions)<br>**HC** | |

---

**Comment for Reporting Person:** Bioceres LLC is an indirect wholly-owned subsidiary of Bioceres Group Limited. As a result, Bioceres Group Limited may be deemed to be the ultimate beneficial owner of Shares held by Bioceres LLC

Row 8 includes 3,076,079 shares that Bioceres LLC has shareholder rights over pursuant to the Shareholders Agreement, dated as of March 5, 2019, by and between Bioceres LLC, Pedro Enrique Mac Mullen, Maria Marta Mac Mullen and International Property Services Corp. See Exhibit 10.1.

| **CUSIP No.** | **G1117K114** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**THEO I SCSp** | Name of reporting person<br>**THEO I SCSp** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**OO** | Source of funds (See Instructions)<br>**OO** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**N4** | Citizenship or place of organization<br>**N4** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**437500.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**437500.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**437500.00** | Aggregate amount beneficially owned by each reporting person<br>**437500.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**0.7%** | Percent of class represented by amount in Row (11)<br>**0.7%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**HC** | Type of Reporting Person (See Instructions)<br>**HC** | |

---

**Comment for Reporting Person:** Bioceres Group Limited owns 96.2 percent of the outstanding equity securities of THEO I SCSp. As a result, Bioceres Group Limited may be deemed to be the ultimate beneficial owner of Shares held by THEO I SCSp.

**Item 1. Security and Issuer**

**(a) Title of Class of Securities:**
Ordinary Shares, $0.0001 par value

**(b) Name of Issuer:**
Bioceres Crop Solutions Corp.

**(c) Address of Issuer's Principal Executive Offices:**
Ocampo 210 bis, Predio CCT, Rosario, Province of Santa Fe, C1, 2000

EXPLANATORY NOTE - This Amendment No. 15 (the "Amendment") amends and supplements the Schedule 13D filed with the Securities and Exchange Commission (the "SEC") on March 14, 2019, (as amended by Amendment No. 1 filed with the SEC on July 2, 2020, Amendment No. 2 filed with the SEC on August 28, 2020, Amendment No. 3 filed with the SEC on November 25, 2020, Amendment No. 4 filed with the SEC on August 6, 2021, Amendment No. 5 filed with the SEC on October 15, 2021, Amendment No. 6 filed with the SEC on April 5, 2022, Amendment No. 7 filed with the SEC on July 25, 2022, Amendment No. 8 filed with the SEC on November 15, 2022, Amendment No. 9 filed with the SEC on March 25, 2024, Amendment No. 10 filed with the SEC on September 20, 2024, Amendment No. 11 filed with the SEC on January 6, 2025, Amendment No. 12 filed with the SEC on March 28, 2025, Amendment No. 13 filed with the SEC on June 10, 2025 and Amendment No. 14 filed with the SEC on July 9, 2025 (the "Schedule 13D"), by Bioceres Group Limited, Bioceres LLC and Theo I SCSp (each a "Reporting Person", and herein collectively referred as the "Reporting Persons").

**Item 4. Purpose of Transaction**

The purpose of the Transactions was to fund the payment of financial obligations which were due.

As a result of the Transactions, the Shares owned by the Reporting Persons, which are not subject to the shareholders' agreement described under Item 6 of the Schedule 13D, decreased from 18,561,323 Shares to  12,421,323 Shares. In addition, 3,076,079 Shares which the Reporting Persons have the shared power to vote or to direct the vote of are subject to the shareholders' agreement described under Item 6 of the Schedule 13D. As a result of the foregoing, in the aggregate, the Reporting Persons beneficially own 15,497,402 Shares (corresponding to approximately 24.7% of the Issuer's outstanding capital stock).

Except for the foregoing, the Reporting Persons have no plans or proposals which relate to, or could result in, any of the matters referred to in Item 4 of Schedule 13D.

**Item 5. Interest in Securities of the Issuer**

**(a)**
Bioceres Group Limited: Amount beneficially owned: 15,497,402 - Percentage: 24.7%

Bioceres LLC: Amount beneficially owned: 14,989,117 - Percentage: 23.8%

THEO I SCSp: Amount beneficially owned: 437,500 - Percentage: 0.7%

**(b)**
Bioceres Group Limited:
Sole power to vote or to direct the vote: 70,785
Shared power to vote or to direct the vote: 15,426,617
Sole power to dispose or to direct the disposition of: 70,785
Shared power to dispose or to direct the disposition of: 12,350,538

Bioceres LLC:
Sole power to vote or to direct the vote: --
Shared power to vote or to direct the vote: 14,989,117
Sole power to dispose or to direct the disposition of: --
Shared power to dispose or to direct the disposition of: 11,913,038

THEO I SCSp
Sole power to vote or to direct the vote: --
Shared power to vote or to direct the vote: 437,500
Sole power to dispose or to direct the disposition of: --
Shared power to dispose or to direct the disposition of: 437,500

**(c)**
None of the Reporting Persons has effected any transactions of the Issuer's Shares during the 60 days preceding the date of this report, except as described in Item 4 of this Schedule 13D/A which information is incorporated herein by reference.

**Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.**

Not applicable.

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Bioceres Group Limited

**Signature:** /s/ Gloria Montaron Estrada

**Name/Title:** Gloria Montaron Estrada/ Attorney-in-Fact

**Date:** 08/07/2025

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Bioceres LLC

**Signature:** /s/ Gloria Montaron Estrada

**Name/Title:** Gloria Montaron Estrada/ Manager

**Date:** 08/07/2025

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** THEO I SCSp

**Signature:** /s/ Gloria Montaron Estrada

**Name/Title:** Gloria Montaron Estrada/ Attorney-in-Fact

**Date:** 08/07/2025